symbol

    R&D

    • icon
        Immunochemical Technology

        BIO/NANO

        The most important raw materials for immunochemical diagnostic products are antibodies.

        We have biotechnology platforms and experience in developing various types of high-quality antibodies, such as structure-specific antibodies, antibodies that distinguish microstructural differences, and neutralizing antibodies used for biopharmaceutical analysis.
        We have various immunoassay development technologies that have high sensitivity and precision, and we are developing various products using these technologies.
        In addition, we possess nanoparticle-related technologies such as gold nanoparticle optimization technology and fluorescent particle manufacturing technology, and they are used as labels for in vitro diagnostic products to achieve high sensitivity and perform more accurate quantitative analysis.


        Antibody Development Technology

        img
        1. 1

          Structure-specific antibody development technology

        2. 2

          Single injection recognition antibody development technology

        3. 3

          Neutralizing antibody development technology

        4. 4

          Antibody characterization and screening technology


        Antibody production using serum-free suspension culture

        img
        1. 1

          Bioreactor-based mass production to produce antibody-based pharmaceuticals

        2. 2

          Ensuring the homogeneity of the raw materials of antibodies

        Rapid diagnosis technology

        img
        1. 1

          Development of immunochromatography using gold nanoparticles
          (coronavirus disease 2019 (COVID-19)-related rapid antigen diagnosis, COVID-19-related rapid antigen and antibody diagnosis, pregnancy/ovulation/menopause hormone test, etc.)


        Antibody production using serum-free suspension culture

        img
        1. 1

          Technology to quantitatively analyze antigen-antibody reactions using fluorescent labels (C-reactive protein (CRP), Total IgE, hemoglobin A1c, etc.)

        2. 2

          High-sensitivity testing possible through time-resolved fluorescence (TRF) technology using Europium particles (Troponin I, PCT , COVID-19-related antigen test, etc.)


        Multiplexed ImmunoBlot

        img
        1. 1

          Immunoassay technology that can test dozens of biomarkers in one strip
          (Allergy-specific antibody test, autoimmune antibody test, etc.)


        ELISA

        img
        1. 1

          Immunoassay technology for analysis using 96-well plates and enzyme conjugates
          (COVID-19-related antibody test, COVID-19-related neutralizing  antibody test, etc.)

        Gold Nanoparticle

        img
        1. 1

          Nanoparticle production technology of uniform size

        2. 2

          Gold Nanoparticle Analysis Technology to ensure Reproducibility

        3. 3

          Ensuring high sensitivity with antibody-gold nanoparticle conjugation technology


        Fluorescent Particle

        img
        1. 1

          Unique fluorescent microsphere production technology(patented)

        2. 2

          Production of fluorescent nanoparticles of uniform size

        3. 3

          Implementation of high sensitivity reporting and photobleaching stability


        A Time-resolved Fluorescent Particles

        img
        1. 1

          High-efficiency conjugation technology by diagnostic markers

        2. 2

          Technology to maximize the signal to noise ratio for high-sensitivity detection